Ha Noi Pharma Joint Stock Company (UPCoM: DHN)

Exchange: UPCoM

Sector: Manufacturing

Industry: Chemical - Pharmaceutical

Listing date: 04/19/2018

Chartered capital: 62,909,000,000

Listed shares: 6,290,900

Shares outstanding: 6,290,900

Status: Operating

Tax code: 0101337659

Establishment license: 8103/QÐ - UB

Issued date: 11/27/2002

Business license: 0103001695

Issued date: 12/24/2002

Main business scope:

- Producing and trading pharmaceutical, cosmetic.

- Exporting pharmaceutical materials, medicines, agricultural and forestry products.

- Importing pharmaceutical materials, equipment, milk, medicines, cosmetic.

- Leasing office, warehouse.

- 22 February 1993: Ha Noi Pharmar State-owned Enterprise was established under the Decision No.784 QD/UB issued by Hanoi City People's Committee;

- 27 November 2002: Hanoi City People's Committee issued the Decision No.8103/QD-UB on transforming Ha Noi Pharmar State-owned Enterprise into Ha Noi Pharmar Joint Stock Company;

- 24 December 2002: Put into operation under the model of a joint stock company with an intial charter capital of VND7.9 billion under the business registration certificate No.0101337659 issued for the first tiem by Hanoi Department of Planning and Investment;

- 04 October 2006: Charter capital was raised up to VND13.9 billion;

- 15 May 2007: Charter capital was raised up to VND17.9 billion;

- 28 December 2007: Charter capital was raised up to VND20.9 billion;

- 2008: Became a public company;

- 06 November 2012: Charter capital was raised up to 62.909.000.000 d?ng;

- 19 April 2018: Traded on UPCOM market;

• 01/17/2024 DHN Dividend payment in cash with 10.00% for 2023 (Record date)
• 01/17/2024 DHN Dividend payment in cash with 10.00% for 2023
• 09/18/2023 DHN Extraordinary General Meeting of Shareholders for 2023
• 08/02/2023 DHN Dividend payment in cash with 10.00% for 2022 (Record date)
• 08/02/2023 DHN Dividend payment in cash with 10.00% for 2022